Centre-based treatment in Czechia yields results, but costs soar

A new analysis by Ernst & Young (EY) for the Czech Association of Innovative Pharmaceutical Industry (AIFP

EURACTIV
Pharma package, Swedish MEPs split ahead of ENVI vote

Swedish Members of the European Parliament welcome updated EU pharma legislation but remain divided on amendme

EURACTIV
Green MEP advocates for keeping paper medicine leaflets

The European Commission's proposed pharmaceutical strategy leaves it to the countries to decide whether drugs'

EURACTIV